| Literature DB >> 31217984 |
Xiao-Jiang Yi1, Xin-Quan Lu1, Hong-Ming Li1, Wei Wang1, Wen-Jun Xiong1, Jin Wan1, De-Chang Diao1.
Abstract
BACKGROUND: According to previous guidelines, the lymph nodes around the right side of the superior mesenteric artery (SMA) should be dissected and removed en bloc. However, due to the technical challenge and the risk of complications, most surgeons perform the dissection along the axis of the superior mesenteric vein (SMV). Herein, we described an 'artery-first' approach for laparoscopic radical extended right hemicolectomy with complete mesocolic excision (CME).Entities:
Keywords: Laparoscopic right hemicolectomy; complete mesocolic excision; ‘artery-first’ approach
Year: 2019 PMID: 31217984 PMCID: PMC6573800 DOI: 10.1093/gastro/goy047
Source DB: PubMed Journal: Gastroenterol Rep (Oxf)
Figure 1.Opening the anterior mesenteric lobe at the junction of the small intestinal mesentery and the right mesocolon. SMV, superior mesenteric vein.
Figure 2.Incising the retroperitoneum in front of the superior mesenteric arteric midline. SMA, superior mesenteric artery; SMV, superior mesenteric vein.
Figure 3.Naking the superior mesenteric vein and dissecting the central group of lymph nodes. SMA, superior mesenteric artery; SMV, superior mesenteric vein; RCV, right colonic vein; ICA, ileocolic artery; ICV, ileocolic vein.
Figure 4.Transecting the anterior lobe at the root of the transverse mesocolon. SMA, superior mesenteric artery; SMV, superior mesenteric vein; RCA, right colonic artery; RCV, right colonic vein; ICV, ileocolic vein; MCA, middle colonic artery; MCV, middle colonic vein.
Figure 5.The whole operative scene after lymph nodes dissection.
Figure 6.Blocking mesenteric lymphatics with biological glue. SMA, superior mesenteric artery; SMV, superior mesenteric vein.
Perioperative data
|
| |
|---|---|
| Sex (male/female) | 9/13 |
| Age, years, mean (range) | 63.1 (39–83) |
| Body mass index, kg/m2, mean (range) | 24.6 (18.3–37.7) |
| Tumor location (ileocecal/ascending colon) | 7/15 |
| Pre-operative clinical staging (I/II/III) | 3/13/6 |
| Conversion (Yes/No) | 0/22 |
| Operative time, minutes, mean (range) | 192.5 (145–240) |
| Intra-operative blood loss, ml, mean (range) | 55.0 (10–300) |
| Intra-operative complication (Yes/No) | 5/22 |
| Bleeding (Yes/No) | 2/2 |
| Subcutaneous emphysema and hypercapnia (Yes/No) | 1 |
| Lymphatic leakage (Yes/No) | 3 |
| Pathological types | |
| Low differentiated adenocarcinoma | 2 |
| Moderately differentiated adenocarcinoma | 17 |
| Highly differentiated adenocarcinoma | 1 |
| Mucous adenocarcinoma | 2 |
| Pathological staging (I/II/III) | 2/17/3 |
| No. of lymph node dissections, mean (range) | 27.0 (13–55) |
| No. of No. D3a lymph nodes, mean (range) | 3.5 (0–8) |
| No. D3a lymph node (positive/negative) | 1/22 |
| 30-day mortality (Yes/No) | 0/22 |
| 30-day re-hospitalization (Yes/No) | 0/22 |
| Post-operative abdominal infection (Yes/No) | 1/22 |
| Increasing number of defecation (Yes/No) | 1/22 |
| Anastomotic leakage (Yes/No) | 0/22 |
| Time to flatus, hours, mean (range) | 35.0 (26–120) |
| Abdominal drainage volume, ml, mean (range) | 766 (560–1570) |
| Indwelling time of abdominal drainage tube, days, mean (range) | 5.0 (3–9) |
| Post-operative hospital stay, days, mean (range) | 5.1 (4–15) |
| Hospitalization time, days, mean (range) | 7.5 (5–20) |